160 related articles for article (PubMed ID: 32537688)
1. Additive effect of erythropoietin use on exercise-induced endothelial activation and hypercoagulability in athletes.
Heuberger JAAC; Posthuma JJ; Ziagkos D; Rotmans JI; Daniels JMA; Gal P; Stuurman FE; Spronk HMH; Ten Cate H; Burggraaf J; Moerland M; Cohen AF
Eur J Appl Physiol; 2020 Aug; 120(8):1893-1904. PubMed ID: 32537688
[TBL] [Abstract][Full Text] [Related]
2. Effects of erythropoietin on cycling performance of well trained cyclists: a double-blind, randomised, placebo-controlled trial.
Heuberger JAAC; Rotmans JI; Gal P; Stuurman FE; van 't Westende J; Post TE; Daniels JMA; Moerland M; van Veldhoven PLJ; de Kam ML; Ram H; de Hon O; Posthuma JJ; Burggraaf J; Cohen AF
Lancet Haematol; 2017 Aug; 4(8):e374-e386. PubMed ID: 28669689
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin does not affect several microvascular parameters in well-trained cyclists.
Birkhoff WAJ; Heuberger JAAC; Post TE; Gal P; Stuurman FE; Burggraaf J; Cohen AF
Physiol Rep; 2018 Dec; 6(24):e13924. PubMed ID: 30592183
[TBL] [Abstract][Full Text] [Related]
4. Importance of serotonergic mechanisms in the thrombotic complications in hemodialyzed patients treated with erythropoietin.
Małyszko JS; Małyszko J; Pawlak K; Pawlak D; Buczko W; Myśliwiec M
Nephron; 2000 Apr; 84(4):305-11. PubMed ID: 10754406
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: results of a double-blind, placebo-controlled, randomized trial.
Tang YD; Hasan F; Giordano FJ; Pfau S; Rinder HM; Katz SD
Am Heart J; 2009 Dec; 158(6):941-7. PubMed ID: 19958860
[TBL] [Abstract][Full Text] [Related]
6. Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration.
Wang G; Durussel J; Shurlock J; Mooses M; Fuku N; Bruinvels G; Pedlar C; Burden R; Murray A; Yee B; Keenan A; McClure JD; Sottas PE; Pitsiladis YP
BMC Genomics; 2017 Nov; 18(Suppl 8):817. PubMed ID: 29143667
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant human erythropoietin on functional and injury endothelial markers in peritoneal dialysis patients.
Aguilera A; Selgas R; Ruiz-Caravaca ML; Bajo MA; Cuesta MV; Plaza MA; Hernanz A
Perit Dial Int; 1999; 19 Suppl 2():S161-6. PubMed ID: 10406511
[TBL] [Abstract][Full Text] [Related]
8. Microdoses of Recombinant Human Erythropoietin Enhance Time Trial Performance in Trained Males and Females.
Breenfeldt Andersen A; Graae J; Bejder J; Bonne TC; Seier S; Debertin M; Eibye K; Hostrup M; Nordsborg NB
Med Sci Sports Exerc; 2023 Feb; 55(2):311-321. PubMed ID: 36317927
[TBL] [Abstract][Full Text] [Related]
9. Long-term erythropoietin therapy does not affect endothelial markers, coagulation activation and oxidative stress in haemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 120(6):797-803. PubMed ID: 17391740
[TBL] [Abstract][Full Text] [Related]
10. The effect of preoperative recombinant human erythropoietin therapy on platelets and hemostasis in patients undergoing cardiac surgery.
Sowade O; Ziemer S; Sowade B; Franke W; Messinger D; Ziebell E; Scigalla P; Warnke H
J Lab Clin Med; 1997 Mar; 129(3):376-83. PubMed ID: 9042823
[TBL] [Abstract][Full Text] [Related]
11. Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans.
Stohlawetz PJ; Dzirlo L; Hergovich N; Lackner E; Mensik C; Eichler HG; Kabrna E; Geissler K; Jilma B
Blood; 2000 May; 95(9):2983-9. PubMed ID: 10779449
[TBL] [Abstract][Full Text] [Related]
12. A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy.
Malyszko J; Malyszko JS; Borawski J; Rydzewski A; Kalinowski M; Azzadin A; Mysliwiec M; Buczko W
Thromb Res; 1995 Jan; 77(2):133-43. PubMed ID: 7740505
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human erythropoietin ameliorated endothelial dysfunction and macrophage infiltration by increasing nitric oxide in hypertensive 5/6 nephrectomized rat aorta.
Toba H; Morishita M; Tojo C; Nakano A; Oshima Y; Kojima Y; Yoshida M; Nakashima K; Wang J; Kobara M; Nakata T
Eur J Pharmacol; 2011 Apr; 656(1-3):81-7. PubMed ID: 21296066
[TBL] [Abstract][Full Text] [Related]
14. Temporal changes in physiology and haematology in response to high- and micro-doses of recombinant human erythropoietin.
Clark B; Woolford SM; Eastwood A; Sharpe K; Barnes PG; Gore CJ
Drug Test Anal; 2017 Oct; 9(10):1561-1571. PubMed ID: 28214385
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant human erythropoietin therapy on blood coagulation and fibrinolysis system.
Kobayashi T; Makuuchi H; Takahashi K; Furuse A; Shibata Y; Tsuno H; Kotsuka Y; Kubota H; Imanaka K; Tsukada T; Nakashima M
Ann Thorac Cardiovasc Surg; 2001 Oct; 7(5):273-7. PubMed ID: 11743853
[TBL] [Abstract][Full Text] [Related]
16. [Changes in endothelial vasoactive substances and blood coagulation and fibrinolysis functions under recombinant human erythropoietin therapy in hemodialysis patients].
Takayama K
Nihon Jinzo Gakkai Shi; 1993 Feb; 35(2):179-88. PubMed ID: 8315881
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin shortens the uraemic bleeding time without causing intravascular haemostatic activation.
Gordge MP; Leaker B; Patel A; Oviasu E; Cameron JS; Neild GH
Thromb Res; 1990 Jan; 57(2):171-82. PubMed ID: 2315882
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive study on hemostasis in CAPD patients treated with erythropoietin.
Malyszko J; Suchowierska E; Malyszko JS; Mysliwiec M
Perit Dial Int; 2002; 22(5):582-92. PubMed ID: 12455569
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 release by erythropoietin involves calcium signaling in endothelial cells.
Carlini RG; Gupta A; Liapis H; Rothstein M
J Cardiovasc Pharmacol; 1995 Dec; 26(6):889-92. PubMed ID: 8606524
[TBL] [Abstract][Full Text] [Related]
20. Use of Aspirin in normalization of recombinant human erythropoietin-mediated hyper-reactivity of platelets in rats.
Soni HM; Vekaria AM; Rath AC; Belemkar S; Jain MR
Indian J Pharmacol; 2014; 46(3):328-33. PubMed ID: 24987182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
